A Phase l/lI, Open-label, Randomised Study of BIBF 1120 Plus mFOLFOX6 Compared to Bevacizumab Plus mFOLFOX6 in Patients with Metastatic Colorectal Cancer
Titel:
A Phase l/lI, Open-label, Randomised Study of BIBF 1120 Plus mFOLFOX6 Compared to Bevacizumab Plus mFOLFOX6 in Patients with Metastatic Colorectal Cancer
Auteur:
Van Cutsem, E. Prenen, H. Guillen-Ponce, C. Bennouna, J. Di Benedetto, M. Bouche, O. Staines, H. Oum'Hamed, Z. Studeny, M. Capdevila, J.